Inaktiver Wert

Onyx Pharmaceuticals, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe	01.10.15
Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma	23.07.15
Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma	31.05.15
Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)	27.05.15
Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio	13.05.15

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+7,52 %	113 Mrd.
REGENERON PHARMACEUTICALS, INC.	+11,38 %	106 Mrd.
BIONTECH SE	-12,64 %	22,22 Mrd.
ARGENX SE	+0,38 %	22,27 Mrd.
GENMAB A/S	-3,62 %	19,43 Mrd.
WUXI APPTEC CO., LTD.	-37,85 %	17,87 Mrd.
BEIGENE, LTD.	-8,58 %	17,24 Mrd.
SAREPTA THERAPEUTICS, INC.	+37,41 %	12,52 Mrd.
LEGEND BIOTECH CORPORATION	-23,95 %	8,34 Mrd.